For Patients & Caregivers

LUNGevity provides information and resources to help patients be more active participants in their healthcare decisions. We also provide support and community to all affected by lung cancer.

Lung Cancer 101

Your comprehensive guide to the basics of lung cancer, including how it develops and the different types

Navigating Your Diagnosis

Information, resources, and important questions to ask at each step of the lung cancer journey

Support Services

The largest online and in-person network of support programs for people affected by lung cancer

Survivor Resource Center

Resources to bridge the practical and emotional gaps in lung cancer survivorship

Caregiver Resource Center

How to ask for help from family and friends, get support from other caregivers, and more

Patient Gateways

Get resources and information tailored for people with your specific type of lung cancer

Helpful Resources

Listings selected to help you find more information and support

COVID-19 and Lung Cancer

Get information about COVID-19 and the vaccines geared toward people with lung cancer.

Latest News & Blogs

There’s Lots to Learn at ILCSC!

The conference presents the latest science behind living well with lung cancer through educational sessions, expert panels, and special breakout groups LUNGevity’s third annual International Lung Cancer Survivorship Conference (ILCSC) is coming up on July 15 and 16. This fully virtual conference

A Survivor’s Experience with Biomarker Testing and TKI Treatments

Back in 2013, when Dan Cadigan was first diagnosed with stage III lung cancer, his treatment options were limited to surgery followed by chemotherapy. However, at his one-year follow-up scan, they found nodules in both lungs and he was diagnosed with stage IV recurrent cancer. Normally, it would

LUNGevity Launches New Rare Mutations and Fusions Patient Gateway

WASHINGTON, DC (June 28, 2022) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, has launched the Rare Mutations and Fusions Lung Cancer Patient Gateway.

New Study Highlights Progress in Drug Development Landscape for Lung Cancer

WASHINGTON, DC (June 22, 2022) – LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, conducted a study analyzing the current global lung cancer drug development landscape.

Dr. Charles Rudin discusses key highlights from ASCO 2022

The American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago June 3-7, 2022. Dr. Upal Basu Roy, Executive Director of Research at LUNGevity Foundation, sat down with Dr. Charles Rudin to discuss key highlights from ASCO 2022 and what they mean for the lung cancer community.

LUNGevity Foundation is proud to be part of the winning Cancer Grand Challenges global team addressing cancer cachexia 

WASHINGTON, DC (June 16, 2022) — LUNGevity is honored to be the US patient advocacy organization that is part of the new Cancer Grand Challenges team taking on t

Palliative Care 101 - Improving Quality of Life While in Treatment

Palliative care, or supportive care, often misunderstood as only end-of-life care, improves patients' quality of life while undergoing treatment. The goal of palliative care is to alleviate the symptoms and side effects caused by lung cancer or its treatment. It also can help you and your family

Conversations That Count: The Black Experience of Lung Cancer

On April 21, LUNGevity’s Director of Community Outreach, Dr. Eugene Manley, Jr., moderated the first in a series of Conversations That Count, titled The Black Experience of Lung Cancer. As part of LUNGevity Foundation’s health equity webinar series, the following panelists came together via

We're Live-Tweeting from ASCO June 3-7!

LUNGevity’s Dr. Upal Basu Roy and Dr. Amy Moore will be live-tweeting from the American Society of Clinical Oncology (ASCO) annual meeting. Follow LUNGevity on Twitter and the hashtags #ASCO22 and #LCSM to be a part of the action. Times and topics of live-tweeted sessions are as follows: Fri, Jun 3

Amgen Receives LUNGevity Foundation Hope Award for Corporate Leadership

WASHINGTON, DC (June 2, 2022) – LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, today announced Amgen Inc. as the recipient of its 2022 Hope Award for Corporate Leadership.

The Importance of Health Disparities Research

In 2021, LUNGevity Foundation announced our inaugural Health Equity and Inclusiveness Workforce Development Awards to help combat the lack of diversity among lung cancer researchers as well as disparities in the lung cancer research itself. To learn more about the health disparities research and

The Stigma of Lung Cancer: A Conversation with Tina Hayden

Living with cancer means processing difficult emotions as well as dealing with side effects and physical changes both during treatment and beyond. Living with lung cancer brings an additional challenge of its own. Lung cancer often comes with a stigma, meaning a lack of respect for a person or

Support Our Work

Your support will help drive advances in lung cancer detection and treatment that are saving lives, and provide free education and support to all affected by lung cancer. Make a tax-deductible donation now, or fundraise with LUNGevity!

DONATE NOW